company background image
1GSN logo

Novanta DB:1GSN Stock Report

Last Price

€147.00

Market Cap

€5.3b

7D

0%

1Y

3.5%

Updated

02 Jan, 2025

Data

Company Financials +

Novanta Inc.

DB:1GSN Stock Report

Market Cap: €5.3b

1GSN Stock Overview

Provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. More details

1GSN fundamental analysis
Snowflake Score
Valuation0/6
Future Growth4/6
Past Performance2/6
Financial Health3/6
Dividends0/6

Rewards

Earnings are forecast to grow 32.55% per year

Risk Analysis

Has a high level of debt

Significant insider selling over the past 3 months


My Notes

Capture your thoughts, links and company narrative

Novanta Inc. Competitors

Jenoptik

XTRA:JEN

€1.3b

Stemmer Imaging

XTRA:S9I

€351.0m

Nynomic

XTRA:M7U

€126.5m

FORTEC Elektronik

XTRA:FEV

€61.1m

Price History & Performance

Summary of share price highs, lows and changes for Novanta
Historical stock prices
Current Share PriceUS$147.00
52 Week HighUS$171.00
52 Week LowUS$139.00
Beta1.27
1 Month Change-8.70%
3 Month Change-5.16%
1 Year Change3.52%
3 Year Change-1.34%
5 Year Change76.05%
Change since IPO38,892.04%

Recent News & Updates

Recent updates

Shareholder Returns

1GSNDE ElectronicDE Market
7D0%-0.02%0.7%
1Y3.5%-14.9%8.4%

Return vs Industry: 1GSN exceeded the German Electronic industry which returned -14.7% over the past year.

Return vs Market: 1GSN underperformed the German Market which returned 8.4% over the past year.

Price Volatility

Is 1GSN's price volatile compared to industry and market?
1GSN volatility
1GSN Average Weekly Movement4.6%
Electronic Industry Average Movement5.2%
Market Average Movement4.9%
10% most volatile stocks in DE Market12.0%
10% least volatile stocks in DE Market2.4%

Stable Share Price: 1GSN has not had significant price volatility in the past 3 months compared to the German market.

Volatility Over Time: 1GSN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19682,900Matthijs Glastrawww.novanta.com

Novanta Inc., together with its subsidiaries, provides precision medicine and manufacturing, medical solutions, and robotics and automation solutions in the United States and internationally. The company operates through three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. The Precision Medicine and Manufacturing segment offers photonics-based solutions, including laser scanning, beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures.

Novanta Inc. Fundamentals Summary

How do Novanta's earnings and revenue compare to its market cap?
1GSN fundamental statistics
Market cap€5.35b
Earnings (TTM)€58.59m
Revenue (TTM)€899.13m

90.2x

P/E Ratio

5.9x

P/S Ratio

Is 1GSN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
1GSN income statement (TTM)
RevenueUS$922.75m
Cost of RevenueUS$517.88m
Gross ProfitUS$404.88m
Other ExpensesUS$344.74m
EarningsUS$60.13m

Last Reported Earnings

Sep 27, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.67
Gross Margin43.88%
Net Profit Margin6.52%
Debt/Equity Ratio61.6%

How did 1GSN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/02 07:51
End of Day Share Price 2025/01/02 00:00
Earnings2024/09/27
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Novanta Inc. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Robert MasonBaird
Ishan MajumdarBaptista Research
Andrew BuscagliaBerenberg